MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF
申请人:Millennium Pharmaceuticals, Inc.
公开号:EP1363890A2
公开(公告)日:2003-11-26
US6699873B1
申请人:——
公开号:US6699873B1
公开(公告)日:2004-03-02
US7375125B2
申请人:——
公开号:US7375125B2
公开(公告)日:2008-05-20
[EN] MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSES DE LIAISON AU RECEPTEUR DE LA MELANOCORTINE-4 ET PROCEDES D'UTILISATION DE TELS COMPOSES
申请人:MILLENNIUM PHARM INC
公开号:WO2002062766A2
公开(公告)日:2002-08-15
MC4-R binding compounds of the formula: B-Z-E (I) wherein B is an anchor moiety, Z is a central moiety, and E is a MC4-R interacting moiety are discussed. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also discussed.
[EN] MELANOCORTIN-4 RECEPTOR BINDING COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSES DE LIAISON DU RECEPTEUR DE LA MELANOCORTINE-4 ET LEURS PROCEDES D'UTILISATION
申请人:GENE LOGIC INC
公开号:WO2005121100A1
公开(公告)日:2005-12-22
Provided are MC4-R binding compounds of the formula XVII: (XVII), wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, Z5, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.